Julphar announces exceptional financial results in profits, revenues, and cash balances for the fiscal year 2024

13^th February 2025, Ras Al Khaimah, UAE: Gulf Pharmaceutical Industries (Julphar), a prominent leading pharmaceutical company in the MENA region, today announced its financial results for the fourth quarter and the full year of 2024.

Julphar continues to deliver strong results and sustain its growth momentum, driven by robust margin expansion, operational excellence, and enhanced financial performance

The Company’s revenues reached AED 1,312.5m, reflecting a 2.7% growth on reported currency from continued operation compared to the same period last year, and 4% growth on constant currency basis.

Profitability sustains its steady growth trend. The company reported profit of AED +40.5m a sharp improvement from AED -98.5m previous year. EBITDA from continued operations tripled versus same period last year and reached AED 144.9 m, exhibiting the successful execution of the strategic and operational efficiency initiatives.

Additionally, Julphar exhibited a disciplined financial position with strong cash flow from operations reaching AED 245.6m, a significant growth from AED 93.6m in the same period last year, driven by effective working capital management and profitability improvement.

Sheikh Saqer Bin Humaid Al Qasimi, Chairman of the Board, Julphar, said: "Serving millions of patients across therapeutic areas, we are confident that our growth mindset and focus on innovation, collaboration and geographical expansion will help us deliver continued positive impact to the healthcare sector and to the knowledge economy in the GCC and beyond. Our Growth Strategy 2030 guides our commitment to deliver excellence in the form of first-to-market products and value-adding medicines.”

Basel Ziyadeh, Chief Executive Officer, Julphar, added: “We have implemented transformational changes across our operating model, positioning the Group to execute our strategy more effectively and drive long-term value creation. These results highlight our continued progress in maintaining a strong balance between business investments, a solid capital structure, and building shareholder value. Our strong market position is reinforced by the dedication of our team across our operating regions.”

-Ends-